drugset / Trial / NCT00557336

Efficacy and Safety of Growth Hormone Treatment in Children Small for Gestational Age

NCT00557336

Phase 3 Completed 160 enrolled Novo Nordisk A/S
Non-randomizedSingle-groupOpen-labelTreatment

Summary

This trial is conducted in Europe. The aim of this clinical trial is to evaluate the height gain during 12 months of growth hormone treatment in children born small for gestational age due to intrauterine growth retardation.

Timeline

Start
2003-07-28
Primary completion
2005-06-29
Completion
2005-06-29

Drugs

EvaluationDrugModalityDoseRoute
Subject Somatropin Protein / enzyme biologic